| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Amantadine: an old drug reborn
|
Pahwa, Rajesh
|
|
|
20 |
12 |
p. 975-977
|
article
|
| 2 |
Amantadine in the treatment of Parkinson's disease and other movement disorders
|
Rascol, Olivier
|
|
|
20 |
12 |
p. 1048-1056
|
article
|
| 3 |
Better buildings for elderly people to thrive
|
O'Connor, Aine
|
|
|
20 |
12 |
p. 988-989
|
article
|
| 4 |
Correction to Lancet Neurol 2018; 17: 1061–82
|
|
|
|
20 |
12 |
p. e7
|
article
|
| 5 |
Correction to Lancet Neurol 2019; 18: 56–87
|
|
|
|
20 |
12 |
p. e7
|
article
|
| 6 |
Correction to Lancet Neurol 2018; 17: 954–76
|
|
|
|
20 |
12 |
p. e7
|
article
|
| 7 |
Correction to Lancet Neurol 2018; 17: 939–53
|
|
|
|
20 |
12 |
p. e7
|
article
|
| 8 |
Correction to Lancet Neurol 2021; 20: 1038–47
|
|
|
|
20 |
12 |
p. e7
|
article
|
| 9 |
Erythropoietin and optic neuritis in the TONE study
|
Costello, Fiona
|
|
|
20 |
12 |
p. 970-971
|
article
|
| 10 |
Gabriel Bsteh
|
|
|
|
20 |
12 |
p. 984
|
article
|
| 11 |
Georgios Tsivgoulis: in top gear
|
Burton, Adrian
|
|
|
20 |
12 |
p. 983
|
article
|
| 12 |
Intracranial pressure monitoring and unfavourable outcomes
|
Welling, Leonardo C
|
|
|
20 |
12 |
p. 978-979
|
article
|
| 13 |
Intracranial pressure monitoring and unfavourable outcomes
|
Chesnut, Randall M
|
|
|
20 |
12 |
p. 978
|
article
|
| 14 |
Intracranial pressure monitoring and unfavourable outcomes – Authors' reply
|
Citerio, Giuseppe
|
|
|
20 |
12 |
p. 979
|
article
|
| 15 |
Lost in plain sight
|
Wijdicks, Eelco
|
|
|
20 |
12 |
p. 987-988
|
article
|
| 16 |
Neuromodulation in epilepsy: state-of-the-art approved therapies
|
Ryvlin, Philippe
|
|
|
20 |
12 |
p. 1038-1047
|
article
|
| 17 |
New therapies for Pompe disease: are we closer to a cure?
|
Puertollano, Rosa
|
|
|
20 |
12 |
p. 973-975
|
article
|
| 18 |
Overall fraction of disease attributable to multiple dependent risk factors: a new formula
|
Niedhammer, Isabelle
|
|
|
20 |
12 |
p. 979-980
|
article
|
| 19 |
Paediatric multiple sclerosis: a lesson from TERIKIDS
|
Sormani, Maria Pia
|
|
|
20 |
12 |
p. 971-973
|
article
|
| 20 |
Safe laboratory management of prions and proteopathic seeds
|
Mead, Simon
|
|
|
20 |
12 |
p. 981
|
article
|
| 21 |
Safety and efficacy of avalglucosidase alfa versus alglucosidase alfa in patients with late-onset Pompe disease (COMET): a phase 3, randomised, multicentre trial
|
Diaz-Manera, Jordi
|
|
|
20 |
12 |
p. 1012-1026
|
article
|
| 22 |
Safety and efficacy of cipaglucosidase alfa plus miglustat versus alglucosidase alfa plus placebo in late-onset Pompe disease (PROPEL): an international, randomised, double-blind, parallel-group, phase 3 trial
|
Schoser, Benedikt
|
|
|
20 |
12 |
p. 1027-1037
|
article
|
| 23 |
Safety and efficacy of erythropoietin for the treatment of patients with optic neuritis (TONE): a randomised, double-blind, multicentre, placebo-controlled study
|
Lagrèze, Wolf A
|
|
|
20 |
12 |
p. 991-1000
|
article
|
| 24 |
Safety and efficacy of teriflunomide in paediatric multiple sclerosis (TERIKIDS): a multicentre, double-blind, phase 3, randomised, placebo-controlled trial
|
Chitnis, Tanuja
|
|
|
20 |
12 |
p. 1001-1011
|
article
|
| 25 |
Supernova: remembering me as I was
|
Morgan, Jules
|
|
|
20 |
12 |
p. 990
|
article
|
| 26 |
20th Anniversary photography competition: neurology for zoomers
|
Becker-Barroso, Elena
|
|
|
20 |
12 |
p. 977
|
article
|
| 27 |
The East Asian Parkinson Disease Genomics Consortium
|
Mok, Kin Y
|
|
|
20 |
12 |
p. 982
|
article
|
| 28 |
The International Brain Initiative: collaboration in progress
|
The Lancet Neurology,
|
|
|
20 |
12 |
p. 969
|
article
|
| 29 |
The International Brain Initiative: enabling collaborative science
|
Quaglio, Gianluca
|
|
|
20 |
12 |
p. 985-986
|
article
|
| 30 |
Trials for neurodegenerative diseases: time to innovate
|
Mehta, Arpan R
|
|
|
20 |
12 |
p. 984
|
article
|
Journal description